Intestinal microbiota as modulators of the immune system and neuroimmune system: Impact on the host health and homeostasis

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Maranduba, Carlos Magno Da Costa ^a   De Castro, Sandra Bertelli Ribeiro ^a   Souza, Gustavo Torres De ^a   Rossato, Cristiano ^b   Da Guia, Francisco Carlos ^a   Valente, Maria Anete Santana ^a   Rettore, João Vitor Paes ^a   Maranduba, Claudinéia Pereira ^a   Souza, Camila Maurmann De ^a   Carmo, Antônio Márcio Resende Do ^a   Macedo, Gilson Costa ^a   Silva, Fernando De Sá ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID;

ACTINOBACTERIA; ALLERGIC ENCEPHALOMYELITIS; BACTEROIDES; BACTEROIDETES; BIFIDOBACTERIUM; CENTRAL NERVOUS SYSTEM; CLOSTRIDIUM; COLORECTAL CANCER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EUBACTERIUM; FAECALIBACTERIUM; FAECALIBACTERIUM PRAUSNITZII; FIRMICUTES; FUSOBACTERIA; FUSOBACTERIUM; HAEMOPHILUS; HEALTH; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; NEUROIMMUNE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEOBACTERIA; REVIEW; RUMINOCOCCACEAE; RUMINOCOCCUS; SPIROCHETE; ULCERATIVE COLITIS; VERRUCOMICROBIA; ANIMAL; AUTOIMMUNE DISEASES; DISEASE MODEL; GASTROINTESTINAL TRACT; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MICROBIOLOGY; NERVOUS SYSTEM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; NERVOUS SYSTEM; NEUROIMMUNOMODULATION; SIGNAL TRANSDUCTION;

EID: 84924567133     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/931574     Document Type: Review

References (110)

1. M. Hamady and R. Knight, "Microbial community profiling for human microbiome projects: tools, techniques, and challenges", Genome Research, vol. 19, no. 7, pp. 1141-1152, 2009.
2. S. R. Gill, M. Pop, R. T. De Boy et al., "Metagenomic analysis of the human distal gut microbiome", Science, vol. 312, no. 5778, pp. 1355-1359, 2006.
3. P. J. Turnbaugh and J. I. Gordon, "The core gut microbiome, energy balance and obesity", The Journal of Physiology, vol. 587, no. 17, pp. 4153-4158, 2009.
4. J. M. Kinross, A. W. Darzi, and J. K. Nicholson, "Gut microbiome-host interactions in health and disease", Genome Medicine, vol. 3, no. 3, article 14, 2011.
5. A. Gonzalez, J. C. Clemente, A. Shade et al., "Our microbial selves: what ecology can teach us", EMBO Reports, vol. 12, no. 8, pp. 775-784, 2011.
6. J. Qin, R. Li, J. Raes et al., "Ahuman gut microbial gene catalogue established by metagenomic sequencing", Nature, vol. 464, no. 7285, pp. 59-65, 2010.
7. D. V. Dimitrov, "The human gutome: nutrigenomics of the host-microbiome interactions", OMICS: A Journal of Integrative Biology, vol. 15, no. 7-8, pp. 419-430, 2011.
8. R. E. Ley, D. A. Peterson, and J. I. Gordon, "Ecological and evolutionary forces shaping microbial diversity in the human intestine", Cell, vol. 124, no. 4, pp. 837-848, 2006.
9. K. Ponnusamy, J. N. Choi, J. Kim, S.-Y. Lee, and C. H. Lee, "Microbial community and metabolomic comparison of irritable bowel syndrome faeces", Journal of Medical Microbiology, vol. 60, no. 6, pp. 817-827, 2011.
10. M. Rajilić-Stojanović, E. Biagi, H. G. H. J. Heilig et al., "Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome", Gastroenterology, vol. 141, no. 5, pp. 1792-1801, 2011.
11. D. M. Saulnier, K. Riehle, T. A. Mistretta et al., "Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome", Gastroenterology, vol. 141, no. 5, pp. 1782-1791, 2011.
12. C. O. Elson, "Genes, microbes, and T cells-new therapeutic targets in Crohn's disease", New England Journal of Medicine, vol. 346, no. 8, pp. 614-616, 2002.
13. C. Manichanh, L. Rigottier-Gois, E. Bonnaud et al., "Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach", Gut, vol. 55, no. 2, pp. 205-211, 2006.
14. Q. Li, C. Wang, C. Tang, N. Li, and J. Li, "Molecularphylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with crohn's disease", PLoS ONE, vol. 7, no. 4, Article ID e34939, 2012.
15. A. D. Kostic, D. Gevers, C. S. Pedamallu et al., "Genomic analysis identifies association of Fusobacterium with colorectal carcinoma", Genome Research, vol. 22, no. 2, pp. 292-298, 2012.
16. L. Thomas, T. Ockhuizen, and K. Suzuki, "Exploring the influence of the gut microbiota and probiotics on health: a symposium report", British Journal of Nutrition, vol. 112, no. 1, pp. S1-S18, 2014.
17. R. E. Ley, "Obesity and the human microbiome", Current Opinion in Gastroenterology, vol. 26, no. 1, pp. 5-11, 2010.
18. J. Qin, Y. Li, Z. Cai et al., "Ametagenome-wide association study of gut microbiota in type 2 diabetes", Nature, vol. 490, no. 7418, pp. 55-60, 2012.
19. S. Michail, M. Durbin, D. Turner et al., "Alterations in the gut microbiome of children with severe ulcerative colitis", Inflammatory Bowel Diseases, vol. 18, no. 10, pp. 1799-1808, 2012.
20. J. L. Round and S. K. Mazmanian, "The gut microbiota shapes intestinal immune responses during health and disease", Nature Reviews Immunology, vol. 9, no. 5, pp. 313-323, 2009.
21. N. M. Delzenne, A. M. Neyrinck, F. Bäckhed, and P. D. Cani, "Targeting gut microbiota in obesity: effects of prebiotics and probiotics", Nature Reviews Endocrinology, vol. 7, no. 11, pp. 639-646, 2011.
22. I. Cho and M. J. Blaser, "The human microbiome: at the interface of health and disease", Nature Reviews Genetics, vol. 13, no. 4, pp. 260-270, 2012.
23. F. Islami and F. Kamangar, "Helicobacter pylori and esophageal cancer risk: a meta-analysis", Cancer Prevention Research, vol. 1, no. 5, pp. 329-338, 2008.
24. C. Belzer and W. M. De Vos, "Microbes inside-from diversity to function: the case of Akkermansia", The ISME Journal, vol. 6, no. 8, pp. 1449-1458, 2012.
25. A. Everard, C. Belzer, L. Geurts et al., "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity", Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 22, pp. 9066-9071, 2013.
26. M. Arumugam, J. Raes, E. Pelletier et al., "Enterotypes of the human gutmicrobiome", Nature, vol. 473, no. 7346, pp. 174-180, 2011.
27. G. D. Wu, J. Chen, C. Hoffmann et al., "Linking long-term dietary patterns with gut microbial enterotypes", Science, vol. 334, no. 6052, pp. 105-108, 2011.
28. C. De Filippo, D. Cavalieri, M. Di Paola et al., "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa", Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14691-14696, 2010.
29. C. Huttenhower, D. Gevers, R. Knight et al., "Structure, function and diversity of the healthy human microbiome", Nature, vol. 486, no. 7402, pp. 207-214, 2012.
30. C. S. Reigstad and P. C. Kashyap, "Beyond phylotyping: understanding the impact of gut microbiota on host biology", Neurogastroenterology and Motility, vol. 25, no. 5, pp. 358-372, 2013.
31. M. Ferrer, A. Ruiz, F. Lanza et al., "Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure", Environmental Microbiology, vol. 15, no. 1, pp. 211-226, 2013.
32. D. Endesfelder, W. Z. Castell, A. Ardissone et al., "Compromised gut microbiota networks in children with anti-islet cell autoimmunity", Diabetes, vol. 63, no. 6, pp. 2006-2014, 2014.
33. H. Williams, I. J. Cox, D. Walker et al., "Characterization of inflammatory bowel disease with urinary metabolic profiling", The American Journal of Gastroenterology, vol. 104, no. 6, pp. 1435-1444, 2009.
34. K. Amato, "Co-evolution in context: the importance of studying gut microbiomes in wild animals", Microbiome Science and Medicine, vol. 1, no. 1, 2014.
35. Q. Aziz, J. Doré, A. Emmanuel, F. Guarner, and E. M. M. Quigley, "Gut microbiota and gastrointestinal health: current concepts and future directions", Neurogastroenterology & Motility, vol. 25, no. 1, pp. 4-15, 2013.
36. B. K. Wershil and G. T. Furuta, "4. Gastrointestinal mucosal immunity", Journal of Allergy and Clinical Immunology, vol. 121, supplement 2, pp. S380-S383, 2008.
37. S. Matamoros, C. Gras-Leguen, F. Le Vacon, G. Potel, and M.-F. De La Cochetiere, "Development of intestinal microbiota in infants and its impact on health", Trends in Microbiology, vol. 21, no. 4, pp. 167-173, 2013.
38. D. R. Littman and E. G. Pamer, "Role of the commensal microbiota in normal and pathogenic host immune responses", Cell Host & Microbe, vol. 10, no. 4, pp. 311-323, 2011.
39. C. L. Maynard, C. O. Elson, R. D. Hatton, and C. T. Weaver, "Reciprocal interactions of the intestinal microbiota and immune system", Nature, vol. 489, no. 7415, pp. 231-241, 2012.
40. J. Petersson, O. Schreiber, G. C. Hansson et al., "Importance and regulation of the colonic mucus barrier in a mouse model of colitis", American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 300, no. 2, pp. G327-G333, 2011.
41. M. Johansson, J. Holmén Larsson, and G. Hansson, "The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions", Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 4659-4665, 2011.
42. Y. Goto and I. I. Ivanov, "Intestinal epithelial cells as mediators of the commensal-host immune crosstalk", Immunology and Cell Biology, vol. 91, no. 3, pp. 204-214, 2013.
43. S. M. Collins, M. Surette, and P. Bercik, "The interplay between the intestinal microbiota and the brain", Nature Reviews Microbiology, vol. 10, no. 11, pp. 735-742, 2012.
44. E. C. Lavelle, C. Murphy, L. A. J. O'Neill, and E. M. Creagh, "The role of TLRs, NLRs, and RLRs inmucosal innate immunity and homeostasis", Mucosal Immunology, vol. 3, no. 1, pp. 17-28, 2010.
45. P. D. Cani, A. Everard, and T. Duparc, "Gut microbiota, enteroendocrine functions and metabolism", Current Opinion in Pharmacology, vol. 13, no. 6, pp. 935-940, 2013.
46. N. Kamada, S. Seo, G. Chen, and G. Núñez, "Role of the gut microbiota in immunity and inflammatory disease", Nature Reviews Immunology, vol. 13, no. 5, pp. 321-335, 2013.
47. S. Fagarasan, S. Kawamoto, O. Kanagawa, and K. Suzuki, "Adaptiveimmune regulation in the gut: T cell-dependent and T cell-independent IgAsynthesis", Annual Review of Immunology, vol. 28, no. 1, pp. 243-273, 2010.
48. A. J. Macpherson, M. B. Geuking, and K. D. McCoy, "Homeland Security: IgA immunity at the frontiers of the body", Trends in Immunology, vol. 33, no. 4, pp. 160-166, 2012.
49. K. Masahata, E. Umemoto, H. Kayama et al., "Generation of colonic IgA-secreting cells in the caecal patch", Nature Communications, vol. 5, article 3704, 2014.
50. K. Atarashi, T. Tanoue, T. Shima et al., "Induction of colonic regulatory T cells by indigenous Clostridium species", Science, vol. 331, no. 6015, pp. 337-341, 2011.
51. M. B. Geuking, J. Cahenzli, M. A. E. Lawson et al., "Intestinal bacterial colonization induces mutualistic regulatory T cell responses", Immunity, vol. 34, no. 5, pp. 794-806, 2011.
52. + T cells in mesenteric lymph nodes and Peyer's patches", European Journal of Microbiology & Immunology, vol. 3, no. 1, pp. 1-10, 2013.
53. Y. Obata, Y. Furusawa, T. A. Endo et al., "The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells", Nature Immunology, vol. 15, no. 6, pp. 571-579, 2014.
54. A. Mortha, A. Chudnovskiy, D. Hashimoto et al., "Microbiotadependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis", Science, vol. 343, no. 6178, Article ID 1249288, 2014.
55. H. Spits, D. Artis, M. Colonna et al., "Innate lymphoid cells-a proposal for uniform nomenclature", Nature Reviews Immunology, vol. 13, no. 2, pp. 145-149, 2013.
56. P. M. Smith, M. R. Howitt, N. Panikov et al., "The microbial metabolites, short-chain fatty acids, regulate colonic T reg cell homeostasis", Science, vol. 341, no. 6145, pp. 569-573, 2013.
57. Y. Furusawa, Y. Obata, S. Fukuda et al., "Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells", Nature, vol. 504, no. 7480, pp. 446-450, 2013.
58. S. Pendyala, J. M. Walker, and P. R. Holt, "A high-fat diet is associated with endotoxemia that originates from the gut", Gastroenterology, vol. 142, no. 5, pp. 1100-1101, 2012.
59. A. Everard and P. D. Cani, "Diabetes, obesity and gut microbiota", Best Practice and Research: Clinical Gastroenterology, vol. 27, no. 1, pp. 73-83, 2013.
60. Y. Cao, J. Shen, and Z. H. Ran, "Association between faecalibacterium prausnitzii reduction and inflammatory bowel disease: ameta-analysis and systematic review of the literature", Gastroenterology Research and Practice, vol. 2014, Article ID 872725, 7 pages, 2014.
61. J. F. Cryan and T. G. Dinan, "Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour", Nature Reviews Neuroscience, vol. 13, no. 10, pp. 701-712, 2012.
62. N. Sudo, Y. Chida, Y. Aiba et al., "Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice", Journal of Physiology, vol. 558, no. 1, pp. 263-275, 2004.
63. M. G. Gareau, E. Wine, D. M. Rodrigues et al., "Bacterial infection causes stress-induced memory dysfunction in mice", Gut, vol. 60, no. 3, pp. 307-317, 2011.
64. P. Bercik, E. F. Verdu, J. A. Foster et al., "Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice", Gastroenterology, vol. 139, no. 6, pp. 2102-2112, 2010.
65. X. Wang, B. R. Wang, X. J. Zhang, Z. Xu, Y. Q. Ding, and G. Ju, "Evidences for vagus nerve in maintenance of immune balance and transmission of immune information from gut to brain in STM-infected rats", World Journal of Gastroenterology, vol. 8, no. 3, pp. 540-545, 2002.
66. L. E. Goehler, R. P. Gaykema, N. Opitz, R. Reddaway, N. Badr, and M. Lyte, "Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni", Brain, Behavior, and Immunity, vol. 19, no. 4, pp. 334-344, 2005.
67. M. N. Silverman and E. M. Sternberg, "Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction", Annals of the New York Academy of Sciences, vol. 1261, no. 1, pp. 55-63, 2012.
68. E. M. Sternberg, "Neuroendocrine regulation of autoimmune/inflammatory disease", Journal of Endocrinology, vol. 169, no. 3, pp. 429-435, 2001.
69. P. Forsythe, "Gut microbes as modulators of the neuroimmunoendocrine system", Pharma Nutrition, vol. 1, no. 4, pp. 115-122, 2013.
70. G. Aston-Jones, M. Ennis, V. A. Pieribone, W. T. Nickell, and M. T. Shipley, "The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network", Science, vol. 234, no. 4777, pp. 734-737, 1986.
71. G. Aston-Jones, J. Rajkowski, P. Kubiak, R. J. Valentino, and M. T. Shipley, "Role of the locus coeruleus in emotional activation.", Progress in brain research, vol. 107, pp. 379-402, 1996.
72. P. Forsythe, J. Bienenstock, and W. A. Kunze, "Vagal pathways for microbiome-brain-gut axis communication", Advances in Experimental Medicine and Biology, vol. 817, pp. 115-33, 2014.
73. L. Arborelius, M. J. Owens, P. M. Plotsky, and C. B. Nemeroff, "The role of corticotropin-releasing factor in depression and anxiety disorders", Journal of Endocrinology, vol. 160, no. 1, pp. 1-12, 1999.
74. Y. Mao, B. Wang, and W. Kunze, "Characterization ofmyenteric sensory neurons in the mouse small intestine", Journal of Neurophysiology, vol. 96, no. 3, pp. 998-1010, 2006.
75. S. D. Brain, "Sensory neuropeptides: their role in inflammation and wound healing", Immunopharmacology, vol. 37, no. 2-3, pp. 133-152, 1997.
76. A. Kavelaars, R. E. Ballieux, and C. J. Heijnen, "The role of IL-1 in the corticotropin-releasing factor and argininevasopressininduced secretion ofimmunoreactive β-endorphin by human peripheral blood mononuclear cells", The Journal of Immunology, vol. 142, no. 7, pp. 2338-2342, 1989.
77. H. J. Westly, A. J. Kleiss, K. W. Kelley, P. K. Wong, and P. H. Yuen, "Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene", The Journal of Experimental Medicine, vol. 163, no. 6, pp. 1589-1594, 1986.
78. P. Affaticati, O. Mignen, F. Jambou et al., "Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells", Cell Death and Differentiation, vol. 18, no. 1, pp. 99-108, 2011.
79. J. E. Blalock, "The immune systemas the sixth sense", Journal of Internal Medicine, vol. 257, no. 2, pp. 126-138, 2005.
80. K. Nakano, T. Higashi, R. Takagi, K. Hashimoto, Y. Tanaka, and S. Matsushita, "Dopamine released by dendritic cells polarizes Th2differentiation", International Immunology, vol. 21, no. 6, pp. 645-654, 2009.
81. P. J. O'Connell, X. Wang, M. Leon-Ponte, C. Griffiths, S. C. Pingle, and G. P. Ahern, "A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells", Blood, vol. 107, no. 3, pp. 1010-1017, 2006.
82. J. E. Blalock, "The syntax of immune-neuroendocrine communication", Immunology Today, vol. 15, no. 11, pp. 504-511, 1994.
83. S. K. Tayebati, D. El-Assouad, A. Ricci, and F. Amenta, "Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes", Journal of Neuroimmunology, vol. 132, no. 1-2, pp. 147-155, 2002.
84. M. D. Warthan, J. G. Freeman, K. E. Loesser et al., "Phenylethanolamine N-methyl transferase expression in mouse thymus and spleen", Brain, Behavior, and Immunity, vol. 16, no. 4, pp. 493-499, 2002.
85. A. Carrillo-Vico, J. R. Calvo, P. Abreu et al., "Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance", The FASEB Journal, vol. 18, no. 3, pp. 537-539, 2004.
86. J. V. Seale, D. S. Jessop, and M. S. Harbuz, "Immunohistochemical staining of endomorphin 1 and 2 in the immune cells of the spleen", Peptides, vol. 25, no. 1, pp. 91-94, 2004.
87. A. Ait-Belgnaoui, H. Durand, C. Cartier et al., "Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats", Psychoneuroendocrinology, vol. 37, no. 11, pp. 1885-1895, 2012.
88. M. T. Bailey, S. E. Dowd, J. D. Galley, A. R. Hufnagle, R. G. Allen, and M. Lyte, "Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation", Brain, Behavior, and Immunity, vol. 25, no. 3, pp. 397-407, 2011.
89. P. Brun, M. C. Giron, M. Qesari et al., "Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system", Gastroenterology, vol. 145, no. 6, pp. 1323-1333, 2013.
90. J. R. Keast, J. B. Furness, and M. Costa, "Somatostatin in human enteric nerves. Distribution and characterization", Cell and Tissue Research, vol. 237, no. 2, pp. 299-308, 1984.
91. E. Ekblad, C. Winther, R. Ekman, R. Håkanson, and F. Sundler, "Projections of peptide-containing neurons in rat small intestine", Neuroscience, vol. 20, no. 1, pp. 169-188, 1987.
92. W. A. Kunze, Y.-K. Mao, B. Wang et al., "Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening", Journal of Cellular and Molecular Medicine, vol. 13, no. 8 B, pp. 2261-2270, 2009.
93. T. Kamiya, L. Wang, P. Forsythe et al., "Inhibitory effects of Lactobocillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats", Gut, vol. 55, no. 2, pp. 191-196, 2006.
94. C. Rousseaux, X. Thuru, A. Gelot et al., "Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors", Nature Medicine, vol. 13, no. 1, pp. 35-37, 2007.
95. R. Wall, R. P. Ross, F. Shanahan et al., "Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues", The American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1393-1401, 2009.
96. M. W. Taylor and G. Feng, "Relationship between interferon-γ, indoleamine 2, 3-dioxygenase, and tryptophan catabolism", The FASEB Journal, vol. 5, no. 11, pp. 2516-2522, 1991.
97. W. R. Wikoff, A. T. Anfora, J. Liu et al., "Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites", Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 10, pp. 3698-3703, 2009.
98. J. R. Oksenberg, S. E. Baranzini, S. Sawcer, and S. L. Hauser, "The genetics of multiple sclerosis: SNPs to pathways to pathogenesis", Nature Reviews Genetics, vol. 9, no. 7, pp. 516-526, 2008.
99. E. Lécuyer, S. Rakotobe, H. Lengliné-Garnier et al., "Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses", Immunity, vol. 40, no. 4, pp. 608-620, 2014.
100. J. Ochoa-Repáraz, D. W. Mielcarz, S. Haque-Begum, and L. H. Kasper, "Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora", Gut Microbes, vol. 1, no. 2, pp. 103-108, 2010.
101. Y. K. Lee, J. S. Menezes, Y. Umesaki, and S. K. Mazmanian, "Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis", Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 4615-4622, 2011.
102. S. Lavasani, B. Dzhambazov, M. Nouri et al., "A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells", PLoS ONE, vol. 5, no. 2, Article ID e9009, 2010.
103. M. Herkenham, A. B. Lynn, M. R. Johnson, L. S. Melvin, B. R. De Costa, and K. Rice, "Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study", The Journal of Neuroscience, vol. 11, no. 2, pp. 563-583, 1991.
104. I. Matias, P. Pochard, P. Orlando, M. Salzet, J. Pestel, and V. Di Marzo, "Presence and regulation of the endocannabinoid systeminhumandendritic cells", European Journal of Biochemistry, vol. 269, no. 15, pp. 3771-3778, 2002.
105. V. Chiurchiù, M. T. Cencioni, E. Bisicchia et al., "Distinct modulation of humanmyeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis", Annals of Neurology, vol. 73, no. 5, pp. 626-636, 2013.
106. M. Aguilera, P. Vergara, and V. Martínez, "Environment-related adaptive changes of gut commensal microbiota do not alter colonic toll-like receptors but modulate the local expression of sensory-related systems in rats", Microbial Ecology, vol. 66, no. 1, pp. 232-243, 2013.
107. K. Wright, N. Rooney, M. Feeney et al., "Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing", Gastroenterology, vol. 129, no. 2, pp. 437-453, 2005.
108. G. D'Argenio, M. Valenti, G. Scaglione, V. Cosenza, I. Sorrentini, and V. D. Di Marzo, "Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation", The FASEB Journal, vol. 20, no. 3, pp. 568-570, 2006.
109. M. Aguilera, P. Vergara, and V. Martúnez, "Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice", Neurogastroenterology and Motility, vol. 25, no. 8, pp. e515-e529, 2013.
110. 9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2", Toxicological Sciences, vol. 131, no. 2, pp. 419-433, 2013.